돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 43846생성일: 2026년 10월 25일

Water → tert-Butyl 4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-oxopiperidine-1-carboxylate

https://huagongshe.com/reaction/43846

반응식

참여 물질

역할이름HCID투입량
반응물WaterHCID 962—
반응물TriethylamineHCID 8471—
반응물tert-Butyl trans(+/-)-4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylateHCID 86648545—
용매Dimethyl SulfoxideHCID 679—
용매DichloromethaneHCID 6344—
생성물tert-Butyl 4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-oxopiperidine-1-carboxylateHCID 68406285120.7%

반응 단계

Triethylamine (374 μL, 2.68 mmol) and sulfur trioxide-pyridine complex (256 mg, 1.61 mmol) were added to a mixed solution of tert-butyl trans(±)-4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-hydroxypiperidine-1-carboxylate synthesized in Example (201b) (100 mg, 0.268 mmol) in dimethyl sulfoxide (1 mL) and dichloromethane (1 mL) at room temperature, and the mixture was stirred at room temperature for 15 hours. Water was added to the reaction solution, followed by extraction with ethyl acetate. The organic layer was washed with water and brine, and dried over anhydrous sodium sulfate. The insoluble matter was separated by filtration, and the filtrate was concentrated under reduced pressure to obtain 120 mg of the title compound as an orange foamy substance, which was used for the next reaction without purification.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08536197B2
출처 데이터셋uspto-grants-2013_09
ORD IDord-776f04e516aa4eaeaf533d0bcbc52b92
출처 메모uspto-grants-2013_09